Glutaredoxin 1

Glutaredoxin 1

Glutaredoxin 1 Molekülinformation

Molecule Name
Glutaredoxin
Molekülalias
GLRX,GRX,TTase-1,GLRX1,GRX1
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
Glutaredoxin-1,Thioltransferase,GRX,GLRX,Glutaredoxin,Thioltransferase-1,TTase-1,Glutaredoxin (Thioltransferase),GRX1,Glutaredoxins
Molekülhintergrund
Glutaredoxin-1 (GRX1) is also known as Thioltransferase-1 (TTase-1), GLRX, GRX, GLRX1, which belongs to the glutaredoxin family. GRX1 / GLRX contains one glutaredoxin domain, which exists in either a reduced or an oxidized form. GRX1 / GLRX has a glutathione-disulfide oxidoreductase activity in the presence of NADPH and glutathione reductase and functions as electron carriers in the glutathione-dependent synthesis of deoxyribonucleotides by the enzymeribonucleotide reductase.

Glutaredoxin 1 Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
DimesnaNSC-716976; BNP-7787; LP-300Phase 2 ClinicalBionumerik
Adenocarcinoma of Lung; Anemia; Breast Diseases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Lung Neoplasms; Neoplasm Metastasis; Neutropenia
Details